Experts Discuss Impact Of New Vaccines On Global Health
This Malaria Policy Center blog post describes the event "Spurring health and wealth through medical breakthroughs," during which Washington Post columnist and ONE Fellow Michael Gerson; John Lusingu, principal research scientist at the Tanzania National Institute for Medical Research and co-principal investigator in the RTS,S malaria vaccine trial in Tanzania for the PATH Malaria Vaccine Initiative; and Margaret McGlynn, board member of the International AIDS Vaccine Initiative and former president of Merck Global Vaccines and Anti-Infectives, "brought unique perspectives to the impact of new vaccines on many global health issues, particularly HIV/AIDS and malaria" (Todd, 6/8).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
